176 related articles for article (PubMed ID: 11876762)
1. IL-15 in human visceral leishmaniasis caused by Leishmania infantum.
Milano S; Di Bella G; D'Agostino P; Barbera C; Caruso R; La Rosa M; Ferlazzo V; Vitale G; La Russa C; Gambino G; Chifari N; Mansueto S; Cillari E
Clin Exp Immunol; 2002 Feb; 127(2):360-5. PubMed ID: 11876762
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
Wolday D; Berhe N; Britton S; Akuffo H
AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
[TBL] [Abstract][Full Text] [Related]
3. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
[TBL] [Abstract][Full Text] [Related]
4. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity of
Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
Front Immunol; 2018; 9():843. PubMed ID: 29740446
[No Abstract] [Full Text] [Related]
7. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with a CD4
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
[TBL] [Abstract][Full Text] [Related]
9. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
[TBL] [Abstract][Full Text] [Related]
10. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.
Bacellar O; Brodskyn C; Guerreiro J; Barral-Netto M; Costa CH; Coffman RL; Johnson WD; Carvalho EM
J Infect Dis; 1996 Jun; 173(6):1515-8. PubMed ID: 8648233
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15, as interferon-gamma, induces the killing of Leishmania infantum in phorbol-myristate-acetate-activated macrophages increasing interleukin-12.
D'Agostino P; Milano S; Arcoleo F; Di Bella G; La Rosa M; Ferlazzo V; Caruso R; Chifari N; Vitale G; Mansueto S; Cillari E
Scand J Immunol; 2004 Dec; 60(6):609-14. PubMed ID: 15584972
[TBL] [Abstract][Full Text] [Related]
14. A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.
Suffia I; Ferrua B; Stien X; Mograbi B; Marty P; Rousseau D; Fragaki K; Kubar J
Infect Immun; 2000 Feb; 68(2):630-6. PubMed ID: 10639426
[TBL] [Abstract][Full Text] [Related]
15. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.
Kemp K; Kemp M; Kharazmi A; Ismail A; Kurtzhals JA; Hviid L; Theander TG
Clin Exp Immunol; 1999 Jun; 116(3):500-4. PubMed ID: 10361241
[TBL] [Abstract][Full Text] [Related]
16. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
17. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Mendonça DVC; Pereira IAG; Santos TTO; Martins VT; Carvalho LM; Freitas CS; Ludolf F; Reis TAR; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Roatt BM; Teixeira AL; Coelho EAF
Cell Immunol; 2020 Oct; 356():104194. PubMed ID: 32827943
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Sundar S; Dube A
PLoS One; 2012; 7(4):e35670. PubMed ID: 22539989
[TBL] [Abstract][Full Text] [Related]
20. Human PBMC proliferative response to Leishmania infantum promastigotes is inhibited by anti-IFN-gamma mAb gamma 123.
Zucca M; Novelli F; Giovarelli M; Caramello P; Garotta G; Musso T; Savoia D
New Microbiol; 1995 Jan; 18(1):53-8. PubMed ID: 7760757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
